JOHNSON & JOHNSON Declares $1.13 Quarterly Dividend

Trending News 🌥️

Johnson & Johnson($NYSE:JNJ) had declared $1.13/share quarterly dividend, in line with previous. Payable Sept. 6; for shareholders of record Aug. 23; ex-div Aug. 22. Dividends are typically paid out four times a year . Johnson & Johnson has been very consistent with their dividend payments, and this recent declaration is in line with what investors have come to expect from the company. While this dividend may not be newsworthy in and of itself, it is important to remember that Johnson & Johnson is a large, publicly traded company. Any time they make a move, it can have an effect on the market, their earnings, and their shareholders. In this case, the dividend declaration is unlikely to have a significant impact on the company in the long term.

Martket Price

On Friday, JOHNSON & JOHNSON stock opened at $167.1 and closed at $169.3, up by 1.5% from last closing price of 166.8.

VI Analysis

JOHNSON & JOHNSON is a diversified healthcare company with operations in pharmaceuticals, medical devices, and consumer products. The company’s fundamentals reflect its long term potential, and based on the VI Risk Rating, JOHNSON & JOHNSON is a medium risk investment in terms of financial and business aspects. However, there are potential risks in the business and financial areas that investors should be aware of.

Summary

JOHNSON & JOHNSON announced today that it has declared a quarterly dividend of $1.13 per share on its common stock. JOHNSON & JOHNSON is a diversified healthcare company with a strong track record of dividend growth. The company has a diversified business model with exposure to multiple growth markets. JOHNSON & JOHNSON has a strong balance sheet with plenty of room for further dividend increases. JOHNSON & JOHNSON is a Dividend Aristocrat with a long history of dividend growth. JOHNSON & JOHNSON is a great dividend growth stock for long-term investors.